Hidden in the wrack: spider (Arachnida, Araneae) diversity and new records for Italy from Posidonia banquettes

Posted by
  Hidden in the wrack: spider (Arachnida, Araneae) diversity and new records for Italy from Posidonia banquettes ABSTRACT Posidonia oceanica (L.) Delile beach wrack deposits (banquettes) are a characteristic coastal habitat of the Mediterranean Sea, yet their invertebrate communities remain poorly studied. Here we report the results of a survey from January to November 2024 of the spider fauna (Order Araneae) associated with Posidonia banquettes at Sant’Agostino beach (Civitavecchia, Latium, central Italy), using four complementary sampling methods (surface and underground pitfall traps, Berlese-Tullgren funnel extraction, and visual census). A total of 161 specimens were collected, with 17 species assigned to 11 families among adult individuals. The dominant families were Argyronetidae (39.4%), represented exclusively by Chaerea maritimus Simon, 1885, and Gnaphosidae (33.8%). Three species are recorded for the first time in Italy: Dysdera gamarrae Ferrández 1984, Gnaphosa jucu...

Could venom-derived therapeutics resolve treatment resistance in refractory EAC?

Posted by

 


Could venom-derived therapeutics resolve treatment resistance in refractory EAC?

Abstract

The incidence of esophageal adenocarcinoma is rising in Western countries. Despite advances in chemotherapy and immunotherapy, the prognosis remains poor, with an overall 5-year survival rate below 15%. A major challenge is the cancer’s poor and often unpredictable response to current treatments. Animal venoms represent a promising yet underexplored source of therapeutic agents, offering millions of structurally diverse and highly potent bioactive peptides that can modulate a wide array of molecular targets. However, only a small fraction of these peptides has been pharmacologically characterized. This review presents the therapeutic potential of venom-derived peptides in cancer treatment, summarizes the role of ion channels in esophageal adenocarcinoma (EAC), and discusses peptides targeting ion channels that may offer new opportunities for future EAC treatment.

Freuville L, Matthys C, Gilliaux Q ...Could venom-derived therapeutics resolve treatment resistance in refractory EAC? Trends in Molecular Medicine, 2026; 0, 
https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(26)00064-X